Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 3,10-dihydroxy-2-naphthacene carboxamide or derivative doai
Patent
1997-03-13
1998-06-30
Weddington, Kevin E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
3,10-dihydroxy-2-naphthacene carboxamide or derivative doai
A61K 3165
Patent
active
057734305
ABSTRACT:
A method for inhibiting the activity of serine proteinase in biological systems includes administering to the system a serine proteinase inhibitory amount of a hydrophobic 4-de(dimethylamino)tetracycline. The method reduces tissue destruction during inflammation resulting from the activity of human leukocyte elastase. The method is used for pharmaceutical and cosmetic purposes.
REFERENCES:
patent: Re34656 (1994-07-01), Golub et al.
patent: 4666897 (1987-05-01), Golub et al.
patent: 4704383 (1987-11-01), McNamara et al.
patent: 4935411 (1990-06-01), McNamara et al.
patent: 4935412 (1990-06-01), McNamara et al.
patent: 5045538 (1991-09-01), Schneider et al.
patent: 5223248 (1993-06-01), McNamara et al.
patent: 5258371 (1993-11-01), Golub et al.
patent: 5308839 (1994-05-01), Golub et al.
patent: 5321017 (1994-06-01), Golub et al.
patent: 5459135 (1995-10-01), Golub et al.
patent: 5523297 (1996-06-01), Pruzanski et al.
patent: 5532227 (1996-07-01), Golub et al.
Simon et al., "Inhibition of Human Neutrophil Elastase by Polyguanylic Acid and Other Synthetic Polynucleotides", Adv. Exp. Med. Biol., 240, 65-74 (1988).
Tyagi et al., "Inhibitors Directed to Binding Domains in Neutrophil Elastase", Biochemistry, 20, 9970-9977 (1990).
Tyagi et al. "Parinaric Acids As Probes of Binding Domains in Neutrophil Elastase ", J. Biol. Chem. 266, 15185-15191 (1991).
Tyagi et al., "Interaction of Neutrophil Elastase With Hydrophobic Polyanionic Chelators", Biochem. Cell. Biol., 69, 624-629 (1991).
Bode et al., "Human Leukocyte and Porcine Pancreatic Elastase: X-Ray Crystal Structures, Mechanism, Substrate Specificity and Mechanism-Based Inhibitors", 28, 1951-1963 (1989).
Yu et al., "Chemically Modified Tetracycline Normalizes Collagen Metabolism in Diabetic Rats", J. Periodontol. Res., 28, 420-428 (1993).
Ramamurthy et al., "Diabetes Increases Collagenase Activity in Extracts of Rat Gingiva and Skin", J. Periodontol. Res., 18, 23-30 (1983).
Roemer et al., "In Vitro Assay Systems for Inflammatory Cell-Mediated Damage to Interstitial Extracellular Matrix", In Vitro Toxicology, 7, 75-81 (1994).
Roemer et al., "In Vitro Assay Systems for Cell Interactions with Interstitial Extracellular Matrix", In Vitro Technology, 7, 209-224 (1994).
Golub et al., "Further Evidence that Tetracyclines Inhibit Collagenase Activity in Human Crevicular Fluid and From Other Mammalian Sources", Journal of Periodontal Research, 20, 12-23 (1985).
Sorsa et al., "Doxycycline in the Protection of Serum Alpha-1-Antitrypsin from Human Neutrophil Collagenase and Gelatinase ", Antimicrobial Agents and Chemotherapy, 37, 592-594 (1993).
Golub et al., "Treating Periodontal Diseases by Blocking Tissue-Destructive Enzymes", JADA, 125, 163-171 (1994).
Mallya et al., "Interaction of Matrix Metalloproteinases with Serine Protease Inhibitors", Annals of the New York Academy of Sciences, 732, 303-314 (1994).
Simon, "Oxidants, Metalloproteases and Serine Proteases in Inflammation", Protease, Protease Inhibitors and Protease-Derived Peptides, 27-37 (1993).
Ying et al., "Inhibition of Human Leucocyte Elastase by Ursolic Acid", Biochem. J., 277, 521-526 (1991).
Cunningham et al., "Synthesis and Evaluation of CE-0266: A New Human Neutrophil Elastase Inhibitor", Bioorganic Chemistry, 20, 345-355 (1992).
Kirschenheuter et al., "Synthesis and Characterization of Human Neutrophil Elastase Inhibitors Derived from Aromatic Esters of Phenylalkanoic Acids", Proteases, Protease Inhibitors and Protease-Derived Peptides, 71-82 (1993).
Chang et al., "Local and Systemic Factors in Periodontal Disease Increase Matrix-Degrading Enzyme Activities in Rat Gingiva: Effect of Minocycline Therapy", Research Communication in Molecular Pathology and Pharmacology, 91, 303-318 (1996).
Ryan et al., "Matrix Metalloproteinases and Their Inhibition in Periodontal Treatment", Current Opinion in Periodontology, 3, 85-96 (1996).
Golub et al., "Tetracyclines Inhibit Connective Tissue Breakdown: New Therapeutic Implications for an Old Family of Drugs", Critical Reviews in Oral Biology and Medicine, 2, 297-322 (1991).
Rinehart et al., "Human .alpha..sub.1 -Proteinase Inhibitor Binds to Extracellular Matrix In Vitro", Am. J. Respir. Cell Mol. Biol., 9, 666-679 (1993).
Mitscher, "Chemical Transformations of the Tetracycline Family", The Chemistry of Tetracyclines, 165-218 (1978).
Golub Lorne M.
Ramamurthy Nungavaram S.
Roemer Elizabeth J.
Simon Sanford R.
Research Foundation of State University of New York
Weddington Kevin E.
LandOfFree
Serine proteinase inhibitory activity by hydrophobic tetracyclin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Serine proteinase inhibitory activity by hydrophobic tetracyclin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Serine proteinase inhibitory activity by hydrophobic tetracyclin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1859455